Future research could aim to elucidate the precise mechanisms linking obesity-related metabolic dysregulations with preeclampsia pathogenesis, as well as to explore novel targets such as ASB4 that could potentially mitigate the impact of maternal obesity on pregnancy outcomes. This evidence concerns the gene ASB4 and obesity due to melanocortin 4 receptor deficiency.